Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
257 participants
OBSERVATIONAL
2015-12-01
2018-02-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The hypothesis of this research study is that exclusive breastfeeding of the infant will provide potential protective effect against cardiometabolic risk factors. This study will also hypothesize that mothers who exclusively breastfeed their newborns would experience greater postpartum weight and body fat loss than mothers who are not breastfeeding.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Breastfeeding Education Support Tool for Baby
NCT03533725
Study on the Construction and Application of Breastfeeding Behavior Intervention Program for Mothers of Infants With Congenital Heart Disease
NCT05961540
Milk Production and Body Weight Response to Suggested Protocol in Obese Lactating Women
NCT06975527
Newborn Feeding and Infant Phenotype
NCT02033005
Effectiveness of Oral Immunotherapy Among Preterm Babies
NCT03633500
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The purpose of this study is to prospectively follow up with the mothers and their infants (from 0-18months of infants age). It will explore breastfeeding and complementary feeding practices of mothers in UAE and its relation to the early life determinants of obesity and non-communicable diseases (NCDs). It will examine the components of human milk which might offer a protective benefit against obesity and its health consequences in infancy. It will also evaluate the feeding practices of the mothers and her nutritional status and relates it to their infants' growth and development.
It is expected that this research study will fill an important knowledge gap in the understanding of the feeding practices of mothers and its relation to early-life determinants of obesity and other chronic diseases in the UAE.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Emirate nationality or Arab expatriate
* Age: 19-40 years
* Singleton pregnancy
* Within the third trimester of pregnancy (27-42 weeks of gestation)
* Free of chronic diseases (diabetes, hypertension, kidney disease, cancer, or other chronic diseases), autoimmune disorders, or infections with the human immunodeficiency virus, or hepatitis in preconception
Exclusion Criteria
* High-risk pregnancy or pre-eclampsia
* History of chronic diseases
* Preterm (\<37 weeks of gestation) or late-term (\>42 weeks of gestation) infants
* Congenital diseases or any health condition that could deter breastfeeding
19 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Al Jalila Foundation
UNKNOWN
University of Sharjah
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hadia Radwan
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hadia Radwan, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Sharjah
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hadia Radwan
Sharjah city, Shajah, United Arab Emirates
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1501057003-P
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.